Biopolitical News of the Year 2013
By Pete Shanks,
Biopolitical Times
| 12. 19. 2013
For better and worse, 2013 has been a year in which several related issues familiar to those who follow human biotechnology moved into the wider sphere of public discussion. Many involve genetic testing – at every stage of life – and some explicitly raise issues of inheritable genetic modification. The legacy of eugenics past, the horror of sterilization abuse in the present, and the advocacy of genetic selection for intelligence and other traits in the near future all hit the headlines.
The U.S. Supreme Court issued a series of important and yet strangely incomplete rulings whose implications are still being unraveled. The commercialization of synthetic biology and other newly developed technologies proceeded apace, with well-financed businesses, partly crowd-sourced ventures and a number of outright scams. The assisted reproduction industry continued its global spread, and there were encouraging signs of academic interest in analyzing its processes.
Here are our picks for the top biopolitical news stories of 2013:
- Testing, Testing …
- “Three-Parent” Babies and Inheritable Genetic Modification
- Eugenics: Past and Present as Prologue
- IQ and Genetics and Education and Immigration
- A...
Related Articles
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...
By Harold Brubaker, The Philadelphia Inquirer | 04.04.2024
Acompany started by University of Pennsylvania scientist Jim Wilson has received FDA approval to test a form of gene editing in infants for the first time in the United States, the company said Thursday.
The Plymouth Meeting company, iECURE, is...
By Judith Levine, The Intercept | 04.04.2024
WHEN THE ALABAMA Supreme Court ruled that fertilized embryos were “extrauterine children,” it did more than imperil the future of in vitro fertilization in Alabama and, potentially, the U.S. The ruling, on the claimed “wrongful death” of frozen embryos...